Skip to main content
. Author manuscript; available in PMC: 2022 Mar 7.
Published in final edited form as: Immunohorizons. 2021 Oct 18;5(10):802–817. doi: 10.4049/immunohorizons.2100083

Table 2.

Most significantly differentially expressed genes on Day 2

Untreated Vs Hemin Hemin Vs Hemin + ARID3a shRNA
Gene Log2 Fold Change Adj P Value Gene Log2 Fold Change Adj P Value
TXNIP 5.24 6.25E-15 SH3BGR 2.29 4.02E-07
OSGIN1 3.68 3.63E-16 HSPA5 2.05 7.51E-10
HBZ 3.52 6.64E-16 HERPUD1 1.83 4.88E-11
AKR1C1 3.01 1.89E-14 ARG2 1.75 2.36E-09
SQSTM1 2.99 1.22E-24 ALDH1A1 1.61 7.07E-07
MCM5 2.74 1.07E-18 NFE4 1.43 3.92E-12
HBA2 2.54 2.68E-15 SEC24D 1.40 3.58E-07
HBE1 2.47 3.58E-21 BEX2 1.29 4.11E-06
NQO1 2.41 2.22E-32 CREG1 1.28 2.85E-06
HBG2 2.12 2.33E-15 LCP1 1.22 4.33E-07
GCLM 2.08 5.83E-19 SERPINH1 1.20 5.91E-06
PPP1R15A 2.05 2.15E-13 RTN4 1.16 3.14E-08
FTL 2.02 3.63E-16 ACOT13 1.15 6.60E-07
HBA1 1.98 3.73E-13 TDP2 1.11 1.49E-07
HBG1 1.94 1.02E-11 TPM4 1.11 4.53E-08
TXNRD1 1.52 9.58E-12 CTSD 1.11 1.78E-08
FTH1 1.47 4.70E-12 PGD 1.05 3.26E-06
CREM 1.41 1.28E-14 ACTB 1.02 2.38E-06
TXN 1.20 6.53E-14 CTSB 1.02 1.39E-06
PRKCSH −1.18 3.70E-16 SND1 0.96 8.32E-07
FKBP2 −1.44 1.47E-11 COPA 0.89 2.56E-07
UCA1 −1.52 6.71E-13 GSR 0.88 2.85E-06
SERPINH1 −1.60 1.47E-11 ANXA5 0.88 1.47E-10
PDIA3 −1.63 2.29E-19 SEC61A1 0.80 1.54E-06
DNAJB11 −1.69 4.11E-14 CALU 0.80 1.71E-09
AC068631.2 −1.95 9.98E-12 SSX1 0.77 1.23E-07
HSP90B1 −1.97 3.99E-19 NQO2 0.73 5.36E-06
HERPUD1 −1.99 2.64E-14 PSMC1 0.68 1.35E-06
NMU −2.01 3.65E-11 SEM1 0.61 4.33E-07
HYOU1 −2.07 7.01E-19 TNNI3 −1.04 8.32E-07
PDIA6 −2.19 2.54E-17 VARS −1.06 2.82E-07
MANF −2.24 8.93E-16 LINC01029 −1.10 1.26E-06
PDIA4 −2.35 1.43E-14 MARCKSL1 −1.14 4.84E-07
HSPA5 −2.35 7.91E-14 HEMGN −1.95 7.51E-10
CALR −2.57 9.34E-17 TXNIP −4.15 9.81E-11